SEC Form 4 · Rule 10b5-1 trading plans
GILEAD SCIENCES, INC. (GILD)
- 26Trades filed under a plan
- 4Plan adoption dates stated
- 7Quarterly results prints on file
- 0Trades in the days before a print
In the 2025 filing year, GILEAD SCIENCES, INC. filed 17 Form 4 statements whose footnotes name a Rule 10b5-1 trading plan, by 4 reporting owners, covering 26 transactions filed under those plans and 391,785 shares. None carries the SEC's own AFF10B5ONE adoption flag; each of the 17 names a plan in a footnote. 7 results prints are on file in the same window, which is what makes the interval below measurable.
Trades filed under a plan in GILEAD SCIENCES, INC. 26
- Dickinson Andrew D — 2025-01-15 · S · 2,500 shares
- Dickinson Andrew D — 2025-01-31 · S · 142,180 shares
- Dickinson Andrew D — 2025-02-12 · S · 137,676 shares
- Dickinson Andrew D — 2025-02-18 · S · 2,500 shares
- Dickinson Andrew D — 2025-03-10 · S · 4,916 shares
- Dickinson Andrew D — 2025-03-10 · S · 13,013 shares
- Dickinson Andrew D — 2025-03-17 · S · 2,500 shares
- O'Day Daniel Patrick — 2025-06-30 · S · 9,400 shares
- O'Day Daniel Patrick — 2025-06-30 · S · 600 shares
- Bluestone Jeffrey — 2025-07-14 · S · 5,000 shares
- Dickinson Andrew D — 2025-07-15 · S · 2,500 shares
- Mercier Johanna — 2025-07-15 · S · 3,000 shares
Plan adoption dates stated in GILEAD SCIENCES, INC. 4
- 2024-08-29 — stated in 9 filings
- 2025-02-13 — stated in 1 filing
- 2025-02-20 — stated in 3 filings
- 2025-02-28 — stated in 4 filings
Quarterly results prints on file in GILEAD SCIENCES, INC. 7
- 2025-02-11
- 2025-04-24
- 2025-08-07
- 2025-10-30
- 2026-02-10
- 2026-05-07
- 2026-08-04
Trades in the days before a print in GILEAD SCIENCES, INC. 0
- 10 days before the 2025-08-07 print — 2025-07-28 · S · O'Day Daniel Patrick · 1,655 shares
- 10 days before the 2025-08-07 print — 2025-07-28 · S · O'Day Daniel Patrick · 8,345 shares
- 11 days before the 2025-02-11 print — 2025-01-31 · S · Dickinson Andrew D · 142,180 shares
- 23 days before the 2025-08-07 print — 2025-07-15 · S · Dickinson Andrew D · 2,500 shares
- 23 days before the 2025-08-07 print — 2025-07-15 · S · Mercier Johanna · 3,000 shares
- 24 days before the 2025-08-07 print — 2025-07-14 · S · Bluestone Jeffrey · 5,000 shares
- 27 days before the 2025-02-11 print — 2025-01-15 · S · Dickinson Andrew D · 2,500 shares
- 31 days before the 2025-10-30 print — 2025-09-29 · S · O'Day Daniel Patrick · 8,039 shares
- 31 days before the 2025-10-30 print — 2025-09-29 · S · O'Day Daniel Patrick · 1,961 shares
- 38 days before the 2025-04-24 print — 2025-03-17 · S · Dickinson Andrew D · 2,500 shares
- 38 days before the 2025-08-07 print — 2025-06-30 · S · O'Day Daniel Patrick · 9,400 shares
- 38 days before the 2025-08-07 print — 2025-06-30 · S · O'Day Daniel Patrick · 600 shares
Interval to the next reported results date
For each transaction filed under a plan, the days between the transaction date and the company’s next results print. These are the dates the filings state, printed as an interval; the page draws no conclusion from them.
- 0Within 5 days of a print
- 2Within 10 days of a print
- 10Shortest interval, in days
- 0Trades with no later print on file
- O'Day Daniel Patrick 2025-07-28 · S · 10 days before the 2025-08-07 print · Chairman & CEO
- O'Day Daniel Patrick 2025-07-28 · S · 10 days before the 2025-08-07 print · Chairman & CEO
Adoption dates, as the filings state them
- 2024-08-29 stated in 9 filings
- 2025-02-13 stated in 1 filing
- 2025-02-20 stated in 3 filings
- 2025-02-28 stated in 4 filings
As the filings state it: “10b5-1 trading plan adopted on February 20, 2025”
Reported results dates on file
- 2025-02-11
- 2025-04-24
- 2025-08-07
- 2025-10-30
- 2026-02-10
- 2026-05-07
- 2026-08-04
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 1
- FMC CORP 2
- ELI LILLY & Co 4
- ABEONA THERAPEUTICS INC. 2
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 12
- Lifevantage Corp 1
- IONIS PHARMACEUTICALS INC 29
- VERTEX PHARMACEUTICALS INC / MA 22
- ARROWHEAD PHARMACEUTICALS, INC. 9
Order the document
Every company with plan records →
Form 4 statements and their footnotes from the SEC’s EDGAR full-text search, and this company’s results dates, industry classification and state of incorporation from the SEC submissions API. The page prints the dates the filings state and the interval between them; it draws no conclusion from them.